Nexusuro: global reach.
A non-thermal, non-implant BPH MIST solution is equally relevant in advanced day-surgery markets and emerging healthcare systems. Nexusuro is actively building international distribution partnerships.
Why non-thermal, non-implant MIST travels well
Some BPH technologies face friction when crossing borders: high equipment costs, complex maintenance, steep learning curves, and regulatory hurdles for drug-coated or implant-based devices. A pure mechanical dilation approach avoids many of these barriers.
The Nexusuro Prostate Dilation System requires no laser generator, no RF console, no capital equipment beyond standard endoscopy — making it viable across diverse healthcare infrastructure levels. The procedure is performed under local anesthesia with sedation, suitable for both hospital and day-surgery settings.
One platform, any infrastructure level
The Nexusuro Prostate Dilation System does not depend on capital-intensive equipment — no laser generator, no RF console, nothing beyond standard endoscopy. That makes it viable across the full spectrum of healthcare infrastructure, from advanced day-surgery centers to hospitals building their first minimally invasive urology program.
High-resource settings
Where day surgery is the norm, non-thermal, non-implant MIST fits naturally into outpatient urology workflows. Procedure under local anesthesia with sedation, same-day discharge — aligned with how advanced systems already operate.
Growing systems
For hospitals expanding urology services without large capital budgets, the low equipment threshold and short learning curve lower the barrier to offering MIST. Standard endoscopy is the only prerequisite.
Regulatory readiness
NMPA registration and ISO 13485 manufacturing provide a foundation for local regulatory submissions. Clear manufacturing disclosure and a focused product path accelerate partner-led registration in each territory.
International regulatory clearances vary by market. Nexusuro is pursuing additional certifications — including FDA and CE marking — as part of its ongoing regulatory roadmap. We work directly with distribution partners on territory-specific requirements.
What international partners receive
Product & clinical documentation
Technical specifications, clinical study literature, and regulatory compliance files for your market registration.
Training & academic support
Product training, clinical communication guidance, and train-the-trainer programs for your local team.
Brand & marketing materials
Consistent international brand assets and adaptable marketing content for local market communication.
Apply for partnership Market opportunity Clinical evidence How it works
Interested in bringing Nexusuro to your market?
We're looking for partners with established urology channels who see the same opportunity we do.
Nexusuro Prostate Dilation System is NMPA registered. International regulatory clearances vary by market. Partnership discussions are subject to applicable laws and regulations in each territory.